Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Indivior

Reckitt hammered by $1.4bn opioid settlement bill

Reckitt hammered by $1.4bn opioid settlement bill

The federal investigation centred on a former Reckitt pharmaceutical subsidiary – spun off in 2014 and renamed Indivior – and marketing practices it deployed for Suboxone between 2006 and 2015. ... Indivior is also in the firing line, and in April

Drug launches to watch in 2019

Drug launches to watch in 2019 Compared with a similar treatment marketed by Indivior, the drug has advantages in flexibility.

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

Horizon Discovery and C4X to harness CRISPR for new cancer drugs C4XD has already had success in this strategy, having signed an outlicensing agreement with Indivior for a pre-clinical addiction programme worth up to $294m.

Indivior push to diversify boosted by schizophrenia drug approval

Indivior push to diversify boosted by schizophrenia drug approval For years, Indivior has made the bulk of its revenues from opioid addiction treatment Suboxone. ... The two approvals come as Indivior is fighting a rearguard action to protect Suboxone from a generic developed by Dr Reddy’s Laboratories.

The year of the blockbuster

The year of the blockbuster Emanating from the pipelines of global pharma giants like Novartis, Johnson &Johnson and Pfizer, as well companies such as Denmark’s Novo Nordisk and Indivior and GW Pharmaceuticals, both of the ... Sublocade (buprenorphine) from Indivior:Sublocade,

1 2 3 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics